2-Anilinoquinoline based arylamides as broad spectrum anticancer agents with B-RAFV600E/C-RAF kinase inhibitory effects: Design, synthesis, in vitro cell-based and oncogenic kinase assessments

Ashraf K. El‐Damasy, Md. Mamunul Haque, Jung Woo Park, Sang Chul Shin, Jun‐Seok Lee, Eunice EunKyeong Kim, Gyochang Keum